Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma levels of interleukin-6 and antidepressant response to Paroxetine in Chinese depressive patients
Zaiquan Dong, Weihong Kuang, Xiaoling Shen, et al.
Psychiatry Research (2021) Vol. 297, pp. 113723-113723
Closed Access | Times Cited: 12

Showing 12 citing articles:

Association of inflammation cytokines with cognitive function in first-episode major depressive disorder
Xi Yali, Z Wang, G. Li, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Potential value of Interleukin-6 as a diagnostic biomarker in human MDD and the antidepressant effect of its receptor antagonist tocilizumab in lipopolysaccharide-challenged rats
Dandan Xu, Yayun Xu, Xinran Gao, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110903-110903
Closed Access | Times Cited: 10
Adipocytokines levels as potential biomarkers for discriminating patients with a diagnosis of depressive disorder from healthy controls
Elżbieta Małujło-Balcerska, Tadeusz Pietras
Journal of Psychiatric Research (2024) Vol. 171, pp. 163-170
Closed Access | Times Cited: 3
The effect of chronic stress on behaviors, inflammation and lymphocyte subtypes in male and female rats
Cai Zhang, Baiping Liu, Jodi L. Pawluski, et al.
Behavioural Brain Research (2022) Vol. 439, pp. 114220-114220
Open Access | Times Cited: 12
Evidence of the Immunomodulatory Effects of Selective Serotonin Reuptake Inhibitors in Patients With Depression Through a Systematic Review
Ankit N Patel, Jagdish Varma, Barna Ganguly
Cureus (2024)
Open Access | Times Cited: 1
Association between TNF-α & IL-6 level changes and remission from depression with duloxetine treatment
Eriko Suzuki, Akitsugu Sueki, Hitoshi Takahashi, et al.
International Journal of Neuroscience (2024), pp. 1-6
Closed Access | Times Cited: 1
Deiodinase Types 1 and 3 and Proinflammatory Cytokine Values May Discriminate Depressive Disorder Patients from Healthy Controls
Elżbieta Małujło-Balcerska, Tadeusz Pietras
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6163-6163
Open Access | Times Cited: 3
Risk of type 2 diabetes mellitus between adolescents with antidepressant-resistant and antidepressant-responsive depression: A cohort study of 15,651 adolescents
Ju‐Wei Hsu, Li-Chi Chen, Kai‐Lin Huang, et al.
Journal of Affective Disorders (2023) Vol. 328, pp. 210-214
Closed Access | Times Cited: 2
Baseline gut microbiota profiles affect treatment response in patients with depression
Yingjing Xie, Hanwen Zhu, Yanling Yuan, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Plasma levels of interleukin‐8 and response to paroxetine in patients with major depressive disorder
Xuan Guan, Zaiquan Dong, Yanni Hao, et al.
Human Psychopharmacology Clinical and Experimental (2022) Vol. 37, Iss. 6
Closed Access | Times Cited: 2
Immunotherapy
Cai Zhang
(2023)
Open Access
Sex Differences in Behaviors and Related Lymphocyte and Inflammatory Mechanisms in a Depression Model of Rats Induced by Chronic Stress
Cai Zhang, Baiping Liu, Jodi L. Pawluski, et al.
SSRN Electronic Journal (2022)
Closed Access
Page 1

Scroll to top